Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mindframe logo — Empowering stroke treatment with rapid flow restoration and...

Mindframe

Empowering stroke treatment with rapid flow restoration and innovative clot extraction devices to enhance clinical outcomes.

Founded 2007 Series C Total: $15.59M Medical Devices

General Information

Company Name Mindframe
Founded Year 2007
Industries Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Mindframe. To contact Mindframe, visit mindframeinc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Mindframe

Mindframe specializes in creating solutions for ischemic stroke patients, focusing on devices that enhance clinical outcomes. Their MindFrame Capture LP device enables quick flow restoration and effective clot removal. Additionally, the company offers the MINDFRAME CAPTURE for ICA-T, basilar arteries, and MCA territory, as well as the MINDFRAME FLOW, which facilitates faster flow restoration for delivering plasminogen activators and plasminogen to thrombus. Established in 2007 and headquartered in Irvine, California, MindFrame has been a subsidiary of Covidien plc since July 2, 2012. The latest investment was a $6.50M Series C investment on 18 May 2012, with investors including CHV Capital, SV Health Investors, and Ascension Ventures.

Taxonomy: Ischemic Stroke, Stroke Treatment, Clot Extraction, Flow Restoration, Clinical Outcomes, Innovative Solutions, MindFrame Capture LP, MINDFRAME CAPTURE, MINDFRAME FLOW, Plasminogen Activators, Covidien Subsidiary, Healthcare Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $6.50M 3
CHV Capital SV Health Investors Ascension Ventures
CHV Capital, SV Health Investors +1
18 May 2012
Convertible Note $2.00M -
05 Jan 2012
Series B $7.09M 3
CHV Capital SV Health Investors Ascension Ventures
CHV Capital, SV Health Investors +1
16 Aug 2010

Mindframe Alternatives & Competitors

View All Alternatives
Mindframe vs
Perfuze
Perfuze Ireland

Neurovascular medical device company developing technology for Ischemic Stroke

Series A
33 employees
Biotechnology, Health Care
Mindframe vs
Innova Vascular, Inc.
Innova Vascular, Inc. United States

Innovators in Vascular Technologies

Non Equity Assistance
8 employees
Health Care, Manufacturing
Mindframe vs
MIVI Neuroscience, Inc
MIVI Neuroscience, Inc United States

The Next Generation of Neurointervention

Series B
18 employees
Health Care, Medical Devices
View all alternatives

FAQ About Mindframe

Empowering stroke treatment with rapid flow restoration and innovative clot extraction devices to enhance clinical outcomes.
Mindframe was founded in 2007.
Mindframe operates in Medical Devices. Its work centres on Ischemic Stroke, Stroke Treatment, Clot Extraction and Flow Restoration.
Mindframe has completed 3 funding rounds, raising a total of $15.59M. The latest funding stage is Series C.
Top alternatives and competitors to Mindframe include Perfuze, Innova Vascular, Inc., MIVI Neuroscience, Inc, WallabyPhenox, TransMedics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mindframe and Perfuze are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Mindframe, https://bouncewatch.com/company/mindframe, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes